Phenyl sulfonamide endothelin antagonists
AssigneeBristol-Myers Squibb Company
InventorsNatesan Murugesan, John T. Hunt, Philip D. Stein
Life of this patent
Estimating the term…
Loading patent…
AssigneeBristol-Myers Squibb Company
InventorsNatesan Murugesan, John T. Hunt, Philip D. Stein
Estimating the term…
Compounds of the formula ##STR1## inhibit the activity of endothelin. The symbols are defined as follows: R.sup.1, R.sup.2 and R.sup.3 are each independently (a) hydrogen, except that R.sup.1 is other than hydrogen; (b) alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, cycloalkylalkyl, cycloalkenyl, cycloalkenylalkyl, aryl, aryloxy, aralkyl or aralkoxy, any of which may be substituted with Z.sup.1, Z.sup.2 and Z.sup.3 ; (c) halo; (d) hydroxyl; (e) cyano; (f) nitro; (g) --C(O)H or --C(O)R.sup.6 ; (h) --CO.sub.2 H or --CO.sub.2 R.sup.6 ; (i) --SH, --S(O).sub.n R.sup.6, --S(O).sub.m --OH, --S(O).sub.m --OR.sup.6, --O--S(O).sub.m --R.sup.6, --O--S(O).sub.m OH or --O--S(O).sub.m --OR.sup.6 ; (j) --Z.sup.4 --NR.sup.7 R.sup.8 ; or (k) --Z.sup.4 --N(R.sup.11 --Z.sup.5 --NR.sup.9 R.sup.10 ; and the remaining symbols are as defined in the specification.
A compound of the formula ##STR8## wherein:
A compound of the formula ##STR9## wherein:
Dependencies are inferred from the claim text.